{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/428099341"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Vrouenraets Saskia M E SM IATEC, Pietersbergweg 9, 1105 BM Amsterdam, The Netherlands. - - 2007 Efavirenz is a non-nucleoside reverse transcriptase inhibitor that in most treatment guidelines is recommended to be taken combined with two nucleoside analogue reverse transcriptase inhibitors, as a preferred first-line regimen for the treatment of HIV-1 infection." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "biomedsearch.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/353260852"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/428099341"] } } }
